Bone Marrow Failure
NEWS RELEASEReleased: April 2, 2021
Defense Health Program
Department of Defense Bone Marrow Failure Research Program
Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
The FY21 Defense Appropriations Act provides funding to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to support research of exceptional merit that focus on bone marrow failure diseases. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
The BMFRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. This pre-announcement should not be construed as an obligation by the Government. The FY21 BMFRP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the Program Announcements are released.
The objective of the FY21 BMFRP is to fund scientifically meritorious research focused on BMF diseases. Investigator‐initiated research is encouraged in the areas of congenital or acquired BMF. Studies focused on BMF syndromes and their progression to other malignancies, such as leukemia, are acceptable. However, research primarily focused on myeloproliferative neoplasms, leukemia, or other malignancies is discouraged. Stem cell biology studies and translational projects, including bone marrow transplantation studies, should be clearly related to BMF diseases.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Idea Development Award||
Established Investigators: Independent investigators at or above the level of Associate Professor (or equivalent); or an Assistant Professor (or equivalent) with greater than 10 years from their first faculty appointment by the application submission deadline or
Early Career Investigators: Independent investigators at the level of Assistant Professor (or equivalent) and within 10 years from first faculty appointment (or equivalent).
|Investigator-Initiated Research Award (IIRA)||Investigators at or above the level of Assistant Professor (or equivalent) by the application submission deadline.||
Funding Level 1:
Funding Level 2: IND-enabling efforts
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for the award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Thursday, May 26, 2022